HK Stock MarketDetailed Quotes
02186 LUYE PHARMA
- 2.750
- +0.030+1.10%
Market Closed Apr 29 16:08 CST
10.34BMarket Cap17.63P/E (TTM)
2.750High2.690Low21.69MVolume2.740Open2.720Pre Close59.03MTurnover0.58%Turnover Ratio17.63P/E (Static)3.76BShares4.03052wk High0.77P/B10.34BFloat Cap2.34052wk Low--Dividend TTM3.76BShs Float11.134Historical High--Dividend LFY2.21%Amplitude1.880Historical Low2.721Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
LUYE PHARMA Key Stats
All
YOY
| (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -39.00%228.99M | 998.32%669.76M | -23.15%375.37M | -107.91%-74.56M | -28.65%488.44M | -42.34%942.17M | -20.71%684.58M | 10.89%1.63B | 28.09%863.4M | 31.99%1.47B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -12.82%-51.27M | 13.06%-88.67M | 17.51%-45.45M | 7.62%-102M | -22.81%-55.09M | -11.79%-110.41M | 2.09%-44.86M | -57.54%-98.76M | -94.48%-45.81M | -126.77%-62.69M |
| Interest expense - adjustment | 43.31%306.84M | ---- | 9.25%214.11M | ---- | -12.11%195.98M | ---- | 84.84%222.98M | ---- | 138.68%120.64M | ---- |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---9.57M | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 96.52%-1.09M |
| Attributable subsidiary (profit) loss | 59.15%-232K | -18.54%-831K | -58.66%-568K | 59.39%-701K | 65.11%-358K | -42.17%-1.73M | -211.85%-1.03M | -35.34%-1.21M | 16.92%-329K | 1.43%-897K |
| Impairment and provisions: | -12.40%6.98M | -94.85%14.07M | --7.97M | --273.48M | --0 | --0 | --0 | --0 | --0 | --0 |
| -Other impairments and provisions | -12.40%6.98M | -94.85%14.07M | --7.97M | --273.48M | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | -292.37%-116.02M | -65.52%21.25M | -234.80%-29.57M | 574.76%61.65M | -6.02%21.94M | 116.48%9.14M | 182.67%23.34M | 10.38%-55.45M | 53.97%-28.23M | ---61.87M |
| -Derivative financial instruments fair value (increase) | ---68.04M | --45.63M | ---- | ---- | ---- | --22.56M | ---- | ---- | ---- | ---- |
| -Other fair value changes | -62.25%-47.97M | -139.54%-24.37M | -234.80%-29.57M | 559.12%61.65M | -6.02%21.94M | 75.78%-13.43M | 182.67%23.34M | 10.38%-55.45M | 53.97%-28.23M | ---61.87M |
| Asset sale loss (gain): | 162.69%126K | 101.87%212K | -221.82%-201K | -12,954.02%-11.36M | 432.26%165K | 99.11%-87K | -80.50%31K | -690.04%-9.78M | -53.24%159K | 22.92%1.66M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 101.87%212K | ---- | -12,954.02%-11.36M | ---- | 99.11%-87K | ---- | -690.04%-9.78M | ---- | 22.92%1.66M |
| -Loss (gain) from selling other assets | 162.69%126K | ---- | -221.82%-201K | ---- | 432.26%165K | ---- | -80.50%31K | ---- | -53.24%159K | ---- |
| Depreciation and amortization: | 1.52%331.43M | 15.35%671.31M | 20.80%326.47M | 13.91%581.98M | 6.11%270.26M | 12.12%510.9M | 17.34%254.69M | 43.66%455.66M | 42.84%217.05M | 26.98%317.19M |
| -Depreciation | 1.52%331.43M | 7.14%367.21M | 20.80%326.47M | 15.90%342.73M | 6.11%270.26M | 19.27%295.7M | 17.34%254.69M | 43.67%247.93M | 42.84%217.05M | 17.48%172.57M |
| -Amortization of intangible assets | ---- | 27.10%304.1M | ---- | 11.18%239.26M | ---- | 3.60%215.2M | ---- | 43.64%207.73M | ---- | 49.66%144.61M |
| Financial expense | ---- | 18.10%471.76M | ---- | -5.79%399.46M | ---- | 43.50%424M | ---- | 73.19%295.46M | ---- | --170.61M |
| Special items | -79.05%10.22M | -25.69%37.11M | 75.94%48.78M | -1.22%49.94M | 395.34%27.72M | -30.01%50.55M | -79.45%5.6M | 126.18%72.22M | 187.21%27.24M | 384.70%31.93M |
| Operating profit before the change of operating capital | -20.05%717.06M | 53.72%1.8B | -5.49%896.92M | -35.97%1.17B | -17.14%949.05M | -20.40%1.82B | -0.76%1.15B | 22.68%2.29B | 44.23%1.15B | 41.00%1.87B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 19.89%-30.67M | 80.16%-26.6M | -165.23%-38.28M | -2,849.56%-134.04M | 1.12%-14.43M | 115.88%4.88M | 72.66%-14.6M | 81.42%-30.7M | 50.96%-53.4M | -611.40%-165.25M |
| Accounts receivable (increase)decrease | -137.11%-403.06M | 91.05%-18.99M | 21.16%-169.99M | -254.85%-212.14M | -46.94%-215.62M | 182.83%137M | 34.90%-146.74M | -37.79%-165.4M | -1,371.92%-225.41M | -5,227.60%-120.04M |
| Accounts payable increase (decrease) | 219.88%123.95M | 43.20%474.79M | -166.02%-103.39M | 139.14%331.57M | 328.25%156.6M | 215.34%138.65M | -88.73%36.57M | -139.88%-120.21M | 22,074.53%324.34M | 1,246.19%301.43M |
| prepayments (increase)decrease | 4.07%647.39M | 105.00%27.85M | 1,310.51%622.07M | -245.49%-556.81M | -7.80%-51.39M | -1,305.11%-161.17M | -321.05%-47.67M | 76.90%-11.47M | -495.05%-11.32M | -351.22%-49.65M |
| Cash from business operations | 17.40%960.23M | 182.01%2.12B | -5.26%817.89M | -50.78%750.24M | 7.28%863.26M | -15.62%1.52B | -7.41%804.7M | 30.69%1.81B | 57.85%869.11M | 14.09%1.38B |
| Other taxs | -108.10%-111.5M | 65.74%-92.77M | 68.20%-53.58M | -68.78%-270.74M | -33.49%-168.51M | 9.16%-160.41M | -25.71%-126.23M | 1.26%-176.59M | 20.19%-100.42M | 8.52%-178.85M |
| Interest paid - operating | 0.53%-159.01M | -24.26%-369.2M | -9.82%-159.86M | 10.06%-297.12M | 15.01%-145.57M | -59.46%-330.36M | -59.72%-171.28M | -31.35%-207.17M | -116.57%-107.24M | -204.47%-157.72M |
| Special items of business | 75.75%-94.44M | -189.52%-137.26M | -1,097.51%-389.44M | 136.54%153.34M | 123.21%39.04M | -165.77%-419.69M | 47.31%-168.19M | 65.11%-157.91M | -151.83%-319.21M | -137.70%-452.64M |
| Net cash from operations | 14.11%689.73M | 806.83%1.65B | 10.06%604.45M | -82.35%182.37M | 8.28%549.18M | -27.36%1.03B | -23.32%507.19M | 36.06%1.42B | 76.26%661.45M | 8.45%1.05B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -4.97%41.46M | -13.88%81.51M | -22.65%43.63M | -7.75%94.65M | 44.00%56.41M | 13.90%102.59M | 49.57%39.17M | 55.16%90.07M | 78.40%26.19M | 138.85%58.05M |
| Dividend received - investment | -99.73%16K | --1.49M | -61.62%5.96M | ---- | -68.88%15.52M | ---- | 53.92%49.89M | -26.23%911K | 2.14%32.41M | -96.90%1.24M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | 202.64%112.19M | --103.8M | -10,109.07%-109.3M | ---- | -96.52%1.09M |
| Decrease in deposits (increase) | -45.49%-80M | -177.19%-858.84M | -37.44%-54.99M | -135.33%-309.84M | -110.16%-40.01M | 178.10%877.06M | 140.33%393.9M | 186.77%315.37M | -1,467.33%-976.67M | -534.29%-363.45M |
| Sale of fixed assets | -97.49%97K | -58.90%5.66M | -13.04%3.86M | 496.10%13.77M | 1,346.58%4.44M | 802.34%2.31M | -84.83%307K | -90.61%256K | -37.12%2.02M | 226.74%2.73M |
| Purchase of fixed assets | ---- | -17.89%-655.68M | ---- | 19.72%-556.2M | ---- | 30.67%-692.81M | ---- | -37.24%-999.34M | ---- | -43.53%-728.17M |
| Purchase of intangible assets | ---- | 48.48%-507.68M | ---- | -34.61%-985.4M | ---- | 64.13%-732.03M | ---- | -16.19%-2.04B | ---- | -1,473.14%-1.76B |
| Recovery of cash from investments | -40.32%555M | 45.89%2.9B | 48.80%930M | -40.24%1.99B | -81.70%625M | -3.95%3.33B | 61.98%3.41B | 13.01%3.46B | -29.87%2.11B | -30.79%3.06B |
| Cash on investment | 2.32%-594.6M | 28.93%-2.63B | 47.61%-608.69M | -25.13%-3.7B | 64.04%-1.16B | 12.87%-2.95B | -37.15%-3.23B | 5.79%-3.39B | 55.46%-2.36B | 21.98%-3.6B |
| Other items in the investment business | ---- | -80.76%3.14M | ---- | -83.20%16.32M | -47.88%7.14M | 133.08%97.16M | -1.04%13.7M | -87.04%41.69M | 72.96%13.84M | 1,107.63%321.64M |
| Net cash from investment operations | -124.40%-78.02M | 51.74%-1.66B | 164.83%319.78M | -2,586.33%-3.44B | -162.84%-493.29M | 105.26%138.2M | 168.28%784.95M | 12.31%-2.63B | 46.60%-1.15B | -303.09%-3B |
| Net cash before financing | -33.81%611.71M | 99.86%-4.51M | 1,553.74%924.22M | -377.70%-3.25B | -95.67%55.89M | 197.15%1.17B | 364.66%1.29B | 38.22%-1.21B | 72.54%-488.23M | -985.71%-1.95B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 64.68%5.53B | -13.82%6.17B | 0.83%3.36B | -2.69%7.16B | -29.69%3.33B | -0.90%7.35B | -6.43%4.74B | -19.53%7.42B | -0.25%5.06B | 138.44%9.22B |
| Refund | -34.45%-5.04B | 17.73%-6.2B | 15.28%-3.75B | -27.81%-7.54B | -1.20%-4.43B | 17.14%-5.9B | 16.68%-4.38B | -19.75%-7.12B | -163.19%-5.25B | -126.01%-5.94B |
| Issuing shares | --696.31M | 61.72%1.69B | ---- | --1.04B | --1.04B | ---- | ---- | --2.04B | ---- | ---- |
| Dividends paid - financing | ---- | ---11M | ---5.5M | ---- | ---- | 50.85%-185.49M | ---5M | -27.97%-377.41M | ---- | -35.34%-294.92M |
| Absorb investment income | ---- | -32.94%825M | ---- | --1.23B | --1.02B | ---- | ---- | --2.86M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---2.14B | ---- | ---- | ---- | -788.35%-77.96M | -780.83%-77.96M | 59.38%-8.78M | ---8.85M | 95.32%-21.61M |
| Pledged bank deposit (increase) decrease | -72.68%123.75M | -71.82%104.88M | 27.11%453.02M | 334.35%372.21M | -46.94%356.4M | -58.67%-158.83M | 143.29%671.65M | 82.04%-100.1M | 144.09%276.07M | -423.00%-557.26M |
| Other items of the financing business | 2,624.99%216.22M | 1.05%-382.32M | 97.69%-8.56M | 50.46%-386.36M | 49.41%-370.52M | -4,548.98%-779.91M | -8,674.45%-732.32M | -1,119.20%-16.78M | -607.05%-8.35M | -39.24%1.65M |
| Net cash from financing operations | 3,235.13%1.52B | -97.12%54.15M | -95.20%45.66M | 639.78%1.88B | 337.84%951.68M | -86.22%253.98M | 213.39%217.36M | -23.33%1.84B | -96.99%69.36M | 228.24%2.4B |
| Effect of rate | 140.68%14.37M | -213.44%-164.15M | -149.95%-35.31M | -146.59%-52.37M | 219.85%70.69M | 1,592.42%112.41M | -696.49%-58.99M | 83.44%-7.53M | 1,199.47%9.89M | 46.41%-45.49M |
| Net Cash | 120.09%2.13B | 103.61%49.64M | -3.74%969.89M | -196.43%-1.37B | -33.25%1.01B | 123.62%1.43B | 460.38%1.51B | 40.89%637.52M | -179.20%-418.87M | -52.52%452.49M |
| Begining period cash | -4.70%2.32B | -36.92%2.44B | -36.92%2.44B | 66.09%3.87B | 66.09%3.87B | 37.12%2.33B | 37.12%2.33B | 34.09%1.7B | 34.09%1.7B | 218.24%1.27B |
| Cash at the end | 32.61%4.47B | -4.70%2.32B | -31.77%3.37B | -36.92%2.44B | 30.86%4.94B | 66.09%3.87B | 193.22%3.78B | 39.12%2.33B | -28.25%1.29B | 32.15%1.67B |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg